Search

everythinglearnresearchcommunity

for

Search:↓

The IPL device is safe, effective, and has high patient satisfaction for hair removal.

Baldness score can't be used to predict prostate size.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Low input with cover crop optimizes yield and reduces greenhouse gas emissions.

The document discusses various nail and hair disorders and their treatments.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Researchers successfully grew human hair follicle cells that could potentially lead to new hair loss treatments.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Blocking JAK-STAT signaling can lead to hair growth.

Male pattern baldness involves genetics, hormones, and needs better treatments.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.